N-terminal pro-brain natriuretic peptide in systemic sclerosis: A new cornerstone of cardiovascular assessment?

Annals of the Rheumatic Diseases

Volumn 68, Issue 12, 2009, Pages 1885-1889

  Allanore, Y ^a   Wahbi, K ^a   Borderie, D ^a   Weber, S ^a   Kahan, A ^a   Meune, C ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; DOPPLER ECHOCARDIOGRAPHY; FEMALE; HEART MUSCLE CONTRACTILITY; HEART VENTRICLE CONTRACTILITY; HUMAN; LUNG ARTERY PRESSURE; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; MITRAL VALVE REGURGITATION; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SYSTEMIC SCLEROSIS; SYSTOLIC BLOOD PRESSURE;

ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; HEART DISEASES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL CONTRACTION; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PROSPECTIVE STUDIES; SCLERODERMA, SYSTEMIC; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 72249093936     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/ard.2008.098087     Document Type: Article

References (38)

1. Kahan A, Allanore Y. Primary myocardial involvement in systemic sclerosis. Rheumatology (Oxford) 2006;45(Suppl 4):IV14-17.
2. Mukerjee D, St George D, Coleiro B, et al. Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach. Ann Rheum Dis 2003;62:1088-1093 (Pubitemid 37323574)
3. Allanore Y, Avouac J, Wipff J, et al. New therapeutic strategies in the management of systemic sclerosis. Expert Opin Pharmacother 2007;8:607-615 (Pubitemid 46547014)
4. Allanore Y, Meune C, Kahan A. Systemic Sclerosis and cardiac dysfunction: evolving concepts and diagnostic methodologies. Curr Opin Rheumatol 2008;20:697-702.
5. de Groote P, Gressin V, Hachulla E, et al. Evaluation of cardiac abnormalities by Doppler echocardiography in a large nationwide multicentric cohort of patients with systemic sclerosis. Ann Rheum Dis 2008;67:31-36
6. Handa R, Gupta K, Malhotra A, et al. Cardiac involvement in limited systemic sclerosis: non-invasive assessment in asymptomatic patients. Clin Rheumatol 1999;18:136-139 (Pubitemid 29223035)
7. Giunta A, Tirri E, Maione S, et al. Right ventricular diastolic abnormalities in systemic sclerosis. Relation to left ventricular involvement and pulmonary hypertension. Ann Rheum Dis 2000;59:94-98
8. Candell-Riera J, Armadans-Gil L, Simeon CP, et al. Comprehensive noninvasive assessment of cardiac involvement in limited systemic sclerosis. Arthritis Rheum 1996;39:1138-1145 (Pubitemid 26240226)
9. Maione S, Cuomo G, Giunta A, et al. Echocardiographic alterations in systemic sclerosis: a longitudinal study. Semin Arthritis Rheum 2005;34:721-727 (Pubitemid 40501508)
10. Mukerjee D, St George D, Coleiro B, et al. Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach. Ann Rheum Dis 2003;62:1088-1093 (Pubitemid 37323574)
11. Hachulla E, Gressin V, Guillevin L, et al. Early detection of pulmonary arterial hypertension in systemic sclerosis: a French nationwide prospective multicenter study. Arthritis Rheum 2005;52:3792-3800 (Pubitemid 41798217)
12. Wigley FM, Lima JA, Mayes M, et al. The prevalence of undiagnosed pulmonary arterial hypertension in subjects with connective tissue disease at the secondary health care level of community-based rheumatologists (the UNCOVER study). Arthritis Rheum 2005;52:2125-2132 (Pubitemid 40994336)
13. Vonk MC, Broers B, Heijdra YF, et al. Systemic sclerosis and its pulmonary complications in The Netherlands: an epidemiological study. Ann Rheum Dis 2009;68:961-965
14. Ferri C, Emdin M, Nielsen H, et al. Assessment of heart involvement. Clin Exp Rheumatol 2003;21(Suppl 29):S24-8.
15. Meune C, Allanore Y, Pascal O, et al. Myocardial contractility is early affected in systemic sclerosis: a tissue Doppler echocardiography study. Eur J Echocardiography 2005;6:351-357 (Pubitemid 41258927)
16. Allanore Y, Meune C, Vignaux O, et al. Bosentan increases myocardial perfusion and function in systemic sclerosis: a magnetic resonance imaging and tissue-Doppler echography study. J Rheumatol 2006;33:2464-2469 (Pubitemid 46067827)
17. Yu CM, Sanderson JE, Marwick TH, et al. Tissue Doppler imaging: a new prognosticator for cardiovascular diseases. J Am Coll Cardiol 2007;49:1903-1914 (Pubitemid 46711162)
18. Meune C, Avouac J, Wahbi K, et al. Cardiac involvement in systemic sclerosis assessed by tissue-Doppler echocardiography during routine care: a controlled study of 100 consecutive patients. Arthritis Rheum 2008;58:1803-1809 (Pubitemid 351847535)
19. Maisel AS, Krishnaswamy P, Nowak RM, et al. Breathing Not Properly Multinational Study Investigators. Rapid measurements of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 2002;347:161-167
20. Januzzi JL, van Kimmenade R, Lainchbury J, et al. NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients: the International Collaborative of NT-proBNP Study. Eur Heart J 2006;27:330-337 (Pubitemid 43100029)
21. Gustafson F, Stensgaard-Hansen F, Badskjaer J, et al. Diagnostic and prognostic performance of N-terminal ProBNP in primary care patients with suspected heart failure. J Card Fail 2005;11(Suppl):S15-20.
22. Jernberg T, Stridsberg M, Venge P, et al. N-terminal pro brain natriuretic peptide on admission for early risk stratification of patients with chest pain and no ST-segment elevation. J Am Coll Cardiol 2002;40:437-445 (Pubitemid 34833157)
23. Weber M, Arnold R, Rau M, et al. Relation of N-terminal pro B-type natriuretic peptide to progression of aortic valve disease. Eur Heart J 2005;26:1023-1030 (Pubitemid 40695033)
24. Nagaya N, Nishikimi T, Uematsu M, et al. Plasma brain natriuretic peptide as a prognostic indicator in patients with primary pulmonary hypertension. Circulation 2000;102:865-870 (Pubitemid 30671502)
25. Allanore Y, Borderie D, Meune C, et al. N-terminal pro-brain natriuretic peptide as a marker of early pulmonary artery hypertension in patients with systemic sclerosis and effects of calcium-channel blockers. Arthritis Rheum 2003;48:3503-3508 (Pubitemid 37531916)
26. Williams MH, Handler CE, Akram R, et al. Role of N-terminal brain natriuretic peptide (N-TproBNP) in scleroderma-associated pulmonary arterial hypertension. Eur Heart J 2006;27:1485-1494 (Pubitemid 43998084)
27. Allanore Y, Borderie D, Avouac J, et al. High N-terminal pro-brain natriuretic peptide levels and low diffusing capacity for carbon monoxide as independent predictors of the occurrence of precapillary pulmonary arterial hypertension in patients with systemic sclerosis. Arthritis Rheum 2008;58:284-291
28. LeRoy EC, Black C, Fleischmajer R, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988;15:202-205 (Pubitemid 18073738)
29. Pellerin D, Sharma R, Elliott P, et al. Tissue Doppler, strain, and strain rate echocardiography for the assessment of left and right systolic ventricular function. Heart 2003;89(Suppl 3):iii9-17.
30. Alam M, Wardell J, Andersson E, et al. Effects of first myocardial infarction on left ventricular systolic and diastolic function with the use of mitral annular velocity determined by pulsed wave Doppler tissue imaging. J Am Soc Echocardiogr 2000;13:343-352 (Pubitemid 30322432)
31. Garcia MJ, Rodriguez L, Ares M, et al. Myocardial wall velocity assessment by pulsed Doppler tissue imaging: characteristics findings in normal subjects. Am Heart J 1996;132:648-656 (Pubitemid 26347772)
32. Meluzín J, Spinarová L, Bakala J, et al. Pulsed Doppler tissue imaging of the velocity of tricuspid annular systolic motion; a new, rapid, and non-invasive method of evaluating right ventricular systolic function. Eur Heart J 2001;22:340-348 (Pubitemid 32622463)
33. Raymond I, Groenning BA, Hildebrandt PR, et al. The influence of age, sex and other variables on the plasma level of N-terminal pro brain natriuretic peptide in a large sample of the general population. Heart 2003;89:745-751 (Pubitemid 36760633)
34. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982;143:29-36.
35. Steen VD, Medsger TA Jr. Severe organ involvement in systemic sclerosis with diffuse scleroderma. Arthritis Rheum 2000;43:2437-2444
36. Cowie MR, Struthers AD, Wood DA, et al. Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care. Lancet 1997;350:1349-1353
37. Wang M, Yip GW, Wang AY, et al. Peak early diastolic mitral annulus velocity by tissue Doppler imaging adds independent and incremental prognostic value. J Am Coll Cardiol 2003;41:820-826 (Pubitemid 36308391)
38. Wang M, Yip GW, Wang AY, et al. Tissue Doppler imaging provides incremental prognostic value in patients with systemic hypertension and left ventricular hypertrophy. J Hypertens 2005;23:183-191 (Pubitemid 40128997)